Results 181 to 190 of about 413,820 (338)

Toward a working definition of ketogenic diet resistance in GLUT1 deficiency syndrome

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective The ketogenic diet (KD) is the standard treatment for glucose transporter type 1 deficiency syndrome (GLUT1‐DS), typically yielding seizure reduction and cognitive/motor gains. However, a small subset of patients shows limited or no clinical benefit.
Raffaele Falsaperla   +8 more
wiley   +1 more source

Correction: Corrigendum: Progesterone receptor modulates ERα action in breast cancer [PDF]

open access: bronze, 2015
Hisham Mohammed   +23 more
openalex   +1 more source

Status epilepticus: Updates on mechanisms and treatments

open access: yesEpilepsia Open, EarlyView.
Abstract Status epilepticus (SE) consists of prolonged, self‐sustaining seizures and is a common neurological emergency that causes respiratory compromise and neuronal injury. Without prompt treatment, the seizures can become resistant to benzodiazepines, leading to the progressive evolution of established, refractory, and super‐refractory SE.
Suchitra Joshi, Jaideep Kapur
wiley   +1 more source

Wearable biosensors based on molecularly imprinted polymers

open access: yesFlexMat, EarlyView.
Wearable biosensors based on molecularly imprinted polymers (MIPs) provide real‐time, non‐invasive monitoring of key biomarkers. This review highlights the research advances on MIPs‐based biosensors with enhanced selectivity, stability, and adaptability in flexible sensing platforms.
Xiangnan Li   +3 more
wiley   +1 more source

Evaluating distant recurrence‐free survival and location of metastasis in HER2+ breast cancer by ER status

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The prognostic significance of the presence or absence of human epidermal growth factor receptor 2 (HER2) and estrogen receptor (ER) in breast cancer is well‐established. However, the relationship of HER2 and ER with distant disease recurrence and metastasis location is less well understood.
Damien Kaukonen   +4 more
wiley   +1 more source

Progesterone receptor (PR) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Progesterone receptor (PR) expression in breast cancer is influenced by menopausal status and PR positivity is more common in premenopausal women. The influence of PR intra‐tumor heterogeneity on distant recurrence risk in premenopausal women, however, remains unknown. In this investigation, variations in PR expression within breast tumors,
Oscar Danielsson   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy